Use and preparation of glycolipids as adjuvants in vaccines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10722574
APP PUB NO 20180344843A1
SERIAL NO

16007685

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to beta-glycolipid derivatives, their preparation and use as adjuvants in vaccines, as being suitable for being co-administered with antigens for vaccine prophylaxis and therapy. In certain embodiments, the beta-glycolipid derivatives of the invention also in their salified or complex form, are suitable for being co-administered with antigens for both therapeutic and prophylactic purposes or for vaccine prophylaxis and therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONSIGLIO NAZIONALE DELLE RICERCHE00185 ROMA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cutignano, Adele Cava de'Tirreni, IT 2 0
De, Palma Raffaele Pratola Serra, IT 2 0
Fontana, Angelo Avellino, IT 3 1
Manzo, Emiliano Naples, IT 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 28, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 28, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00